Nutritional Growth Solutions Past Earnings Performance
Past criteria checks 0/6
Nutritional Growth Solutions's earnings have been declining at an average annual rate of -1.5%, while the Personal Products industry saw earnings growing at 8.7% annually. Revenues have been growing at an average rate of 1.2% per year.
Key information
-1.5%
Earnings growth rate
28.1%
EPS growth rate
| Personal Products Industry Growth | -25.2% |
| Revenue growth rate | 1.2% |
| Return on equity | n/a |
| Net Margin | -99.3% |
| Last Earnings Update | 30 Jun 2024 |
Recent past performance updates
Recent updates
Revenue & Expenses Breakdown
How Nutritional Growth Solutions makes and spends money. Based on latest reported earnings, on an LTM basis.
Earnings and Revenue History
| Date | Revenue | Earnings | G+A Expenses | R&D Expenses |
|---|---|---|---|---|
| 30 Jun 24 | 3 | -3 | 3 | 0 |
| 31 Mar 24 | 3 | -3 | 3 | 0 |
| 31 Dec 23 | 3 | -3 | 4 | 0 |
| 30 Sep 23 | 3 | -3 | 4 | 0 |
| 30 Jun 23 | 3 | -4 | 5 | 0 |
| 31 Mar 23 | 3 | -4 | 5 | 0 |
| 31 Dec 22 | 3 | -4 | 5 | 0 |
| 30 Sep 22 | 3 | -4 | 5 | 1 |
| 30 Jun 22 | 3 | -5 | 5 | 1 |
| 31 Mar 22 | 3 | -5 | 5 | 1 |
| 31 Dec 21 | 3 | -5 | 5 | 1 |
| 30 Sep 21 | 3 | -5 | 5 | 1 |
| 30 Jun 21 | 3 | -6 | 4 | 1 |
| 31 Mar 21 | 2 | -5 | 4 | 0 |
| 31 Dec 20 | 2 | -4 | 3 | 0 |
| 30 Sep 20 | 2 | -3 | 3 | 0 |
| 30 Jun 20 | 2 | -2 | 2 | 0 |
| 31 Mar 20 | 1 | -2 | 2 | 0 |
| 31 Dec 19 | 1 | -2 | 2 | 0 |
| 31 Dec 18 | 1 | 0 | 2 | 0 |
Quality Earnings: NGS is currently unprofitable.
Growing Profit Margin: NGS is currently unprofitable.
Free Cash Flow vs Earnings Analysis
Past Earnings Growth Analysis
Earnings Trend: NGS is unprofitable, and losses have increased over the past 5 years at a rate of 1.5% per year.
Accelerating Growth: Unable to compare NGS's earnings growth over the past year to its 5-year average as it is currently unprofitable
Earnings vs Industry: NGS is unprofitable, making it difficult to compare its past year earnings growth to the Personal Products industry (10.2%).
Return on Equity
High ROE: NGS's liabilities exceed its assets, so it is difficult to calculate its Return on Equity.